Bionano Genomics, Inc. (BNGO) Stock Overview
Explore Bionano Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Bionano Genomics, Inc. (BNGO)
Key Financials
Key Financials
Market Cap
12.3M
P/E Ratio
-0.18
EPS (TTM)
$-4.37
ROE
-0.71%
BNGO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Bionano Genomics, Inc. (NASDAQ: BNGO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Bionano Genomics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BNGO on the NASDAQ shows an RSI of 40.62, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Bionano Genomics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.18 and a market capitalization of 12.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BNGO on the NASDAQ.